论文部分内容阅读
我院近5年来,应用免疫药物治疗慢性肝炎323例和重症肝炎44例。其中治疗慢性肝炎的药物和方法有溶菌酶(65例)、青霉胺(48例)、聚肌胞(19例)、转移因子(15例)、左旋咪唑(9例)、中药紫参针(131例)、抗澳片(18例,由青黛、明矾、姜黄等中药组成)及小剂量胎盘丙种球蛋白足三里等穴位注射和足三里穴位埋线疗法(共18例)。治疗重症肝炎的药物和方法有环磷酰胺与正常人体转移因子联合应用(2例)、乙型肝炎免疫球蛋白(3例)和肾上腺皮质激素——地塞米松静脉注射法(29例)、小剂量地塞米松足三里穴位注射法(10例)。治疗前后观察肝功能、HBsAg、免疫学及临床等各项指标。现将结果摘要报告如下:
Nearly 5 years in our hospital, the application of immune drugs in the treatment of 323 cases of chronic hepatitis and 44 cases of severe hepatitis. The treatment of chronic hepatitis drugs and methods are lysozyme (65 cases), penicillamine (48 cases), polymyosarcoma (19 cases), transfer factor (15 cases), levamisole (9 cases) (131 cases), anti-O-piece (18 cases, composed of indigo, alum and turmeric) and small dose of placental gammaglobulin (Zusanli) acupoint injection and Zusanli acupoint catgut implantation therapy (18 cases in total). The treatment of severe hepatitis drugs and methods are cyclophosphamide and normal human transfer factor combination (2 cases), hepatitis B immunoglobulin (3 cases) and adrenal cortex hormone - dexamethasone intravenous injection (29 cases) A small dose of dexamethasone acupuncture at Zusanli (10 cases). Before and after treatment observed liver function, HBsAg, immunology and clinical indicators. The summary of results is now reported as follows: